Smith Michael David
Insider CIK 1777800 · KALV Senior VP, Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-05-17 | 2022-05-19 | 15,480 | — | $0 | 15,480 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-05-17 | 2022-05-19 | 10,320 | — | $0 | 10,320 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2021-06-01 | 2021-06-03 | 7,500 | — | $0 | 22,596 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2021-06-01 | 2021-06-03 | 7,500 | $8.39 | $62.9K | 7,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-06-01 | 2021-06-03 | 7,500 | $26.83 | $201.2K | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-05-26 | 2021-05-28 | 35,000 | — | $0 | 35,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2021-04-28 | 2021-04-30 | 10,014 | — | $0 | 30,096 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2021-04-28 | 2021-04-30 | 10,014 | $8.39 | $84.0K | 10,014 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-04-28 | 2021-04-30 | 10,014 | $25.76 | $258.0K | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-02-07 | 2021-02-08 | 16,500 | — | $0 | 16,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2020-12-16 | 2020-12-18 | 25,000 | — | $0 | 25,000 | SEC↗ |